Sanofi SNY
Rating
Rating Factors
Company Overview
Sanofi is a global biopharmaceutical company focused on the research, development, manufacturing, and commercialization of medicines and vaccines across multiple therapeutic areas. The company operates primarily within the pharmaceuticals and vaccines industries, with a strategic emphasis on innovative specialty care, immunology, oncology, rare diseases, and preventive healthcare. Its core revenue drivers include prescription medicines, specialty biologics, and vaccines sold to governments, healthcare systems, and private providers.
Founded in 1973 through the merger of several French pharmaceutical entities and later expanded through major acquisitions, Sanofi evolved into a global healthcare leader. A pivotal milestone was the 2004 merger with Aventis, which significantly expanded its R&D capabilities and international footprint. In recent years, Sanofi has repositioned itself toward science-driven innovation, streamlining legacy businesses while increasing investment in biologics and immunology to strengthen long-term growth.
Income Statement
Balance Sheet
Cash Flow
Filings
Price History
- Low
- $40.89
- Current
- $40.89
- High
- $52.68
Valuation
Dividends and Shares
Corporate Info
Paris, 75017